company-logo

Hyloris Pharmaceuticals SA engages in the develop, manufacture, and deliver pharmaceutical products to address unmet medical needs in cardiovascular health, oncology, women's health, and other major therapeutic areas. The company offers cardiovascular products for atrial fibrillation, acute coronary syndrome, advanced heart failure, congestive heart failure, acute coronary syndrome, and coronary heart disease. It also provides other products, such as post operation pain, dental indications, severe and recurring vulvovaginal candidiasis, acute myeloid leukemia and small cell lung cancer, IC/PBS, attention deficit hyperactivity disorder, and viral infection. Hyloris Pharmaceuticals SA was incorporated in 2012 and is headquartered in Liège, Belgium.

Hyloris Pharmaceuticals Dividend Announcement

Hyloris Pharmaceuticals does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
Stay tuned for updates on Hyloris Pharmaceuticals dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Hyloris Pharmaceuticals Dividend History

Hyloris Pharmaceuticals Dividend Yield

Hyloris Pharmaceuticals current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Hyloris Pharmaceuticals stock? Use our calculator to estimate your expected dividend yield:

Hyloris Pharmaceuticals Financial Ratios

P/E ratio-13.25
PEG ratio-0.13
P/B ratio4.09
ROE-28.53%
Payout ratio0.00%
Current ratio5.22
Quick ratio5.22
Cash Ratio4.50

Hyloris Pharmaceuticals Dividend FAQ

Does Hyloris Pharmaceuticals stock pay dividends?
Hyloris Pharmaceuticals does not currently pay dividends to its shareholders.
Has Hyloris Pharmaceuticals ever paid a dividend?
No, Hyloris Pharmaceuticals has no a history of paying dividends to its shareholders. Hyloris Pharmaceuticals is not known for its dividend payments.
Why doesn't Hyloris Pharmaceuticals pay dividends?
There are several potential reasons why Hyloris Pharmaceuticals would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Hyloris Pharmaceuticals ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Hyloris Pharmaceuticals has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Hyloris Pharmaceuticals a dividend aristocrat?
Hyloris Pharmaceuticals is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Hyloris Pharmaceuticals a dividend king?
Hyloris Pharmaceuticals is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Hyloris Pharmaceuticals a dividend stock?
No, Hyloris Pharmaceuticals is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Hyloris Pharmaceuticals stocks?
To buy Hyloris Pharmaceuticals you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Hyloris Pharmaceuticals stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.